A Fundação Champalimaud, formalmente Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud, é uma fundação portuguesa, sem fins lucrativos, com a finalidade de desenvolver atividades de pesquisa científica no campo da medicina.

During the past decade, Fundacao Champalimaud conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 5 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 5 clinical trials were completed. i.e. 22.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacao Champalimaud" #1 sponsor was "Fundacao Champalimaud" with 6 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Taiho Oncology, Inc." with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacao Champalimaud" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Breast European Adjuvant Studies Team" with 1 trials as a collaborator and "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Fundacao Champalimaud" are "Breast Cancer" (3 trials), "Depressive Disorder, Major" (3 trials), "Multiple Myeloma" (2 trials), "Urinary Bladder Neoplasms" (2 trials) and "Adenocarcinoma of the Prostate" (1 trials). Many other conditions were trialed in "Fundacao Champalimaud" in a lesser frequency.

Most popular intervention types in "Fundacao Champalimaud" are "Drug" (28 trials), "Radiation" (7 trials), "Biological" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Gemcitabine" (3 trials), "Aticaprant" (2 trials), "Carboplatin" (2 trials) and "Cetrelimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fundacao Champalimaud" are 25 trials for "All" genders, 8 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Fundacao Champalimaud". undefined are not yet recruiting, 16 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Fundacao Champalimaud, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundacao Champalimaud, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

Fundacao Champalimaud has several departments that took part in Clinical trials: "Centro Clinico Champalimaud; Oncologia Medica" - 6 trials